| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |